We are live on
!
Find out more
GP
Geneva Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
72.91%
This Fund
S&P 500
This Quarter
Est. Return
+10.79%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$11M
(+10%)
Cap. Flow
+$7.66M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
40.71%
Holding
69
New
15
Increased
9
Reduced
31
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$4.44M |
| 2 |
Mastercard
MA
|
+$4.21M |
| 3 |
Meta Platforms (Facebook)
META
|
+$4.08M |
| 4 |
Parker-Hannifin
PH
|
+$4M |
| 5 |
TransDigm Group
TDG
|
+$3.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$5.87M |
| 2 |
Cheniere Energy
LNG
|
+$4.19M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.08M |
| 4 |
Elevance Health
ELV
|
+$2.13M |
| 5 |
McKesson
MCK
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.87% |
| 2 | Industrials | 15.13% |
| 3 | Technology | 13.83% |
| 4 | Consumer Staples | 12.34% |
| 5 | Energy | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PepsiCo
PEP
$196B
| $6.39M | 5.47% |
35,038
-1,491
| -4% | -$261K |
|
2
iShares Core S&P 500 ETF
IVV
$858B
| $5.68M | 4.86% |
13,807
-1,004
| -7% | -$403K |
|
3
Merck
MRK
$322B
| $5.45M | 4.67% |
51,246
-2,114
| -4% | -$228K |
|
|
4
Meta Platforms (Facebook)
META
$1.49T
| $5.08M | 4.35% |
+23,983
| New | +$4.08M |
|
|
5
Mastercard
MA
$498B
| $4.57M | 3.91% |
12,563
+11,601
| +1,206% | +$4.21M |
|
|
6
Boeing
BA
$169B
| $4.54M | 3.88% |
+21,357
| New | +$4.44M |
|
7
Microsoft
MSFT
$2.9T
| $4.13M | 3.53% |
14,309
-316
| -2% | -$80.6K |
|
|
8
Parker-Hannifin
PH
$120B
| $4.06M | 3.47% |
+12,080
| New | +$4M |
|
|
9
TransDigm Group
TDG
$70.7B
| $4.04M | 3.45% |
+5,478
| New | +$3.91M |
|
10
Analog Devices
ADI
$172B
| $3.65M | 3.13% |
+18,523
| New | +$3.32M |
|
11
Fidelity Dividend ETF for Rising Rates
FDRR
$730M
| $3.55M | 3.04% |
87,259
+372
| +0.4% | +$15.1K |
|
12
Chevron
CVX
$382B
| $3.52M | 3.01% |
21,559
-5,889
| -21% | -$987K |
|
13
ASML
ASML
$596B
| $3.5M | 2.99% |
+5,136
| New | +$3.3M |
|
14
Hershey
HSY
$37.3B
| $3.36M | 2.87% |
13,206
-2,592
| -16% | -$609K |
|
|
NVO
15
Novo Nordisk
NVO
$228B
| $3.26M | 2.79% |
41,002
-700
| -2% | -$49.6K |
|
16
Alphabet (Google) Class A
GOOGL
$4.12T
| $3.09M | 2.64% |
29,765
-150
| -0.5% | -$14.4K |
|
17
Amgen
AMGN
$209B
| $3.02M | 2.58% |
12,480
-1,240
| -9% | -$304K |
|
18
Williams Companies
WMB
$85.8B
| $2.58M | 2.21% |
86,529
-44,415
| -34% | -$1.37M |
|
19
Philip Morris
PM
$309B
| $2.55M | 2.18% |
26,217
+2,363
| +10% | +$235K |
|
|
20
Elevance Health
ELV
$81.5B
| $2.44M | 2.09% |
5,310
-4,484
| -46% | -$2.13M |
|
21
Cummins
CMI
$83.6B
| $2.42M | 2.07% |
10,111
+3,315
| +49% | +$809K |
|
22
Broadcom
AVGO
$1.76T
| $2.15M | 1.84% |
+33,530
| New | +$2.02M |
|
23
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
| $2.14M | 1.83% |
17,255
-163
| -0.9% | -$19.6K |
|
24
Monster Beverage
MNST
$95.1B
| $2.13M | 1.82% |
39,422
-3,000
| -7% | -$154K |
|
25
Oneok
OKE
$56.7B
| $1.91M | 1.64% |
30,136
-10,178
| -25% | -$676K |
|
Similar funds
SWM
BWM
EPG
MCP
EM
MIM
MIP
FHWM
Geneva Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Geneva Partners held 69 positions worth $117M, up 10% from $106M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Geneva Partners deployed $7.66M of net new capital in Q1 2023, opening 15 new positions and adding to 9 existing holdings. Its largest new stake was Boeing: 21,357 shares worth $4.54M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Elevance Health, an estimated $2.13M trimmed.
- Geneva Partners's largest Q1 2023 buy was Boeing: 21,357 shares worth $4.54M.
- Geneva Partners added most to Mastercard in Q1 2023, an estimated $4.21M increase.
- Geneva Partners's biggest Q1 2023 reduction was Elevance Health, cutting an estimated $2.13M.
- Geneva Partners fully exited Lockheed Martin in Q1 2023, selling an estimated $5.87M.
- Geneva Partners's ten largest holdings make up 41% of its $117M portfolio in Q1 2023.
- Geneva Partners opened 15 new positions and closed 9 in Q1 2023.
- Geneva Partners's portfolio value rose 10% quarter-over-quarter to $117M.
Based on Geneva Partners's 13F filing for Q1 2023, filed 26 Apr 2023.